Search
Filters
Clear All
  • 7
  • 40
  • 2
  • 518

Phase

  • 9
  • 10
  • 35
  • 6
  • 53
  • 6
  • 430
  • 516
  • 256

Found 567 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

J
Jenny Belsky, DO
5 years - 60 years
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is in …
Learn More

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA)

L
Lisa Landrum, MD, PhD, MS
18 years or above
All genders
Phase 3
Interventional
What is the purpose of this study?GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.THIS STUDY IS ENROLLING BY INVITATION …
Learn More

Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM)

S
Suparna C. Clasen, MD, MSCE
18 years or above
All genders
Phase 3
Interventional
What is the purpose of this study?The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first …
Learn More

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

A
Anthony Ross
18 years or below
All genders
Phase 2/3
Interventional
What is the purpose of this study?The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate …
Learn More

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

N
Namita Agrawal
18 years or above
Female
Interventional
What is the purpose of this study?The purpose of this study is to examine the feasibility of adding pre-rehabilitation pelvic health physical therapy to standard of care radiation therapy treatment plan for female patients who have been diagnosed with cervical, vaginal, vulvar, uterine, or anal cancer and are a candidate …
Learn More

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

S
Suparna C. Clasen, MD, MSCE
40 years or above
Male
Interventional
What is the purpose of this study?This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer who are either planning to begin, or are currently taking androgen deprivation therapy (ADT) . THIS STUDY IS ENROLLING BY INVITATION ONLY - …
Learn More

DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

M
Michael Ferguson, MD
25 years or below
All genders
Phase 3
Interventional
What is the purpose of this study?This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in patients with pediatric low-grade glioma (LGG) harboring an activating rapidly accelerated fibrosarcoma (RAF) alteration requiring front-line …
Learn More

OnX Liver Assessment Solution Clinical Study

R
Raj Vuppalanchi, MD
22 years - 80 years
All genders
Interventional
What is the purpose of this study?This protocol’s primary aim is to assess the performance of the OnX exam on patients with suspected or confirmed liver disease with the goal of comparing the OnX output stiffness estimates to FibroScan® liver stiffness measurements. Our primary objectives are to assess whether the …
Learn More

A Phase 3, Randomized, Double-blind, Active-controlled Study to Evaluate a Switch to an Oral Weekly Islatravir/Lenacapavir Regimen in People With HIV-1 Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir (B/F/TAF)

S
Samir Gupta, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?The goal of this clinical study is to learn about the safety and efficacy of switching to once weekly tablet of islatravir/lenacapavir (ISL/LEN) regimen versus continuing standard treatment of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in people with human immunodeficiency virus (PWH) who are virologically suppressed (HIV-1 …
Learn More

A Non-Interventional Survey Study on the Preferences of Patients with AtrialFibrillation and Physicians Treating Atrial Fibrillation for Anticoagulant Treatment Outcomes

M
Michael Moran, MD
18 years - 100 years
All genders
Interventional
What is the purpose of this study?To identify the relative importance of attributes of anticoagulant treatment to AF patients and physicians that treat AF patients To quantify the tradeoffs that patients and physicians are willing to make between attributes associated with anticoagulant treatment.THIS STUDY IS ENROLLING BY INVITATION ONLY - …
Learn More
51 - 60 of 567